Hepion Pharmaceuticals, Inc. (HEPA) Capital expenditures 2016–2024
Hepion Pharmaceuticals, Inc. (HEPA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$14,304FY2024 · since FY2016: $6,603 → $14,304
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $14,304 | -12.4% |
| FY2023 | $16,336 | -87.5% |
| FY2022 | $130,405 | +48.2% |
| FY2021 | $87,983 | +70.9% |
| FY2020 | $51,469 | — |
| FY2017 | $14,709 | +122.8% |
| FY2016 | $6,603 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice